| [Fire Fighting] Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire. | |
| [Ingestion] Seek medical attention. If individual is drowsy or unconscious, do not give anything by mouth; place individual on the left side with the head down. Contact a physician, medical facility, or poison control center for advice about whether to induce vomiting. If possible, do not leave individual unattended. | |
| [Inhalation] If symptoms develop, move individual away from exposure and into fresh air. If symptoms persist, seek medical attention. If breathing is difficult, administer oxygen. Keep person warm and quiet; seek immediate medical attention. | |
| [Skin] Flush skin with plenty of soap and water for at least 15 minutes while removing contaminated clothing and shoes. | |
| [Eyes] If symptoms develop, immediately move individual away from exposure and into fresh air. Flush eyes gently with water for at least 15 minutes while holding eyelids apart; seek immediate medical attention. | |
| [Storage] Store in a cool, dry location. Keep containers tightly sealed. | |
| [Handling] Use only in a chemical fume hood. Only handly while using the recommended protective equipment. Remove and launder contaminated clothing and shoes before reuse. | |
| [Inhalation] Irritation, headache.. Reproductive disorders. COngestive heart failure. | |
| [Skin] Irritation. | |
| [Eyes] Irritation. | |
| [Ingestion] Harmful if swallowed. Nausea. | |
| [Personal Protection] Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots. | |
| [Respirators] NIOSH/MSHA approved respirator. | |
| [Exposure Effects] Initially CNS depression is seen, followed by CNS stimulation. Drowsiness, weakness, confusion, jitteriness, hallucinations, nightmares and apprehension have been reported as has aggressive behavior and seizures after a single 800 mg dose. | |
| [Appearance] Off-white to pale-yellow powder. | |
| [Solubility in water] Insoluble | |
| [Melting Point] 82 | |
| [Boiling Point] 214 | |
| [Partition Coefficient] 2.47 | |
| [Usage] Medication (vet). | |
| [Product Name] Amantadine | |
| [Synonyms] 1-Aminoadamantane Adamantan-1-amine | |
| [CAS] "CASEN_768-94-5.htm">768-94-5 | |
| [Formula] C10H17N | |
| [Molecular Weight] 151.25 | |
| [EINECS] 212-201-2 | |
| [RTECS] YD1925000 | |
| [RTECS Class] Drug; Mutagen | |
| [Merck] 12,389 | |
| [Beilstein/Gmelin] 2204333 | |
| [Small spills/leaks] Evacuate area. Wear SCB A, rubber boots and gloves. Sweep up, place in a bag and hold for waste disposal. Avoid raising dust. Provide adequate ventilation. Wash site after material pickup is complete. | |
| [Stability] Stable at normal temperatures and pressures. | |
| [Incompatibilities] Strong oxidizing agents. | |
| [Decomposition] Oxides of carbon and nitrogen. |
Print